Competition and the Efficiency of Markets for Technology

References

• Allain ML, Henry E, Kyle M (2013) Competition and the efficiency of markets for technology. Technical Report 784, Institut d’Économie Industrielle, University of Toulouse 1 Capitole, Toulouse, France.Google Scholar
• Anand B, Khanna T (2000) The structure of licensing contracts. J. Indust. Econom. 48(1):103–135.Crossref, Google Scholar
• Angell M (2004) The Truth About the Drug Companies: How They Deceive Us and What to Do About It (Random House, New York).Google Scholar
• Anton JJ, Yao DA (2002) The sale of ideas: Strategic disclosure, property rights and contracting. Rev. Econom. Stud. 69(3): 513–531.Crossref, Google Scholar
• Arora A, Gambardella A (2010) Ideas for rent: An overview of markets for technology. Indust. Corporate Change 19(3):775–803.Crossref, Google Scholar
• Arora A, Fosfuri A, Gambardella A (2001) Markets for Technology: The Economics of Innovation and Corporate Strategy (MIT Press, Cambridge, MA).Crossref, Google Scholar
• Arrow KJ (1971) Essays in the Theory of Risk-Bearing (North-Holland, Amsterdam).Google Scholar
• Beggs AW (1992) The licensing of patents under asymmetric information. Internat. J. Indust. Organ. 10(2):171–191.Crossref, Google Scholar
• Bulow J, Klemperer P (2002) Prices and the winner’s curse. RAND J. Econom. 33(1):1–21.Crossref, Google Scholar
• Choi JP (2001) Technology transfer with moral hazard. Internat. J. Indust. Organ. 19(1–2):249–266.Crossref, Google Scholar
• Cockburn I (2007a) Is the market for technology working well? Obstacles to licensing and ways to overcome them. Conference on the Economics of Technology Policy, June 17–22, École polytechnique fédérale de Lausanne, Lausanne,Switzerland.Google Scholar
• Cockburn I (2007b) Is the pharmaceutical industry in a productivity crisis? Jaffe A, Lerner J, Stern S, eds. Innovation Policy and the Economy, Vol. 7 (MIT Press, Cambridge, MA), 1–32.Google Scholar
• Danzon PM, Nicholson S, Pereira N (2005) Productivity in pharmaceutical-biotechnology R&D: The role of experience and alliances. J. Health Econom. 24(2):317–339.Crossref, Google Scholar
• Economist, The (2006) The tortoise and the hare: The search for innovation. Economist (January 19), http://www.economist.com/node/5380472.Google Scholar
• Fletcher L (2002) Pfizer-Pharmacia merger bodes ill for biotech? Nature Biotech. 20(9):857–858.Crossref, Google Scholar
• Galasso A, Simcoe TS (2011) CEO overconfidence and innovation. Management Sci. 57(8):1469–1484.Link, Google Scholar
• Gans JS, Hsu DH, Stern S (2008) The impact of uncertain intellectual property rights on the market for ideas: Evidence from patent grant delays. Management Sci. 54(5):982–997.Link, Google Scholar
• Guedj I, Scharfstein D (2004) Organizational scope and investment: Evidence from the drug development strategies and performance of biopharmaceutical firms. NBER Working Paper 10933, National Bureau of Economic Research, Cambridge, MA.Crossref, Google Scholar
• Hayward MLA, Shepherd DA, Griffin D (2006) A hubris theory of entrepreneurship. Management Sci. 52(2):160–172.Link, Google Scholar
• Hegde D (2014) Tacit knowledge and the structure of license contracts: Evidence from the biomedical industry. J. Econom. Management Strategy 23(3):568–600.Crossref, Google Scholar
• Higgins MJ (2007) The allocation of control rights in pharmaceutical alliances. J. Corporate Finance 13(1):58–75.Crossref, Google Scholar
• Kamien M, Tauman Y (1986) Fees vs. royalties and the private value of a patent. Quart. J. Econom. 101(3):471–491.Crossref, Google Scholar
• Lerner J, Malmendier U (2010) Contractibility and the design of research agreements. Amer. Econom. Rev. 100(1):214–246.Crossref, Google Scholar
• Lerner J, Merges RP (1998) The control of technology alliances: An empirical analysis of the biotechnology industry. J. Indust. Econom. 46(2):125–156.Crossref, Google Scholar
• Levine A (2007) Licensing and scale economies in the biotechnology pharmaceutical industry. Working paper, Stanford University, Stanford, CA.Google Scholar
• Lowe RA, Ziedonis AA (2006) Overoptimism and the performance of entrepreneurial firms. Management Sci. 52(2):173–186.Link, Google Scholar
• Luo H (2014) When to sell your idea: Theory and evidence from the movie industry. Management Sci. 60(12):3067–3086.Link, Google Scholar
• Malmendier U, Tate G (2005) CEO overconfidence and corporate investment. J. Finance 60(6):2661–2770.Crossref, Google Scholar
• Mendi P (2005) The structure of payments in technology transfer contracts: Evidence from Spain. J. Econom. Management Strategy 14(2):403–429.Crossref, Google Scholar
• Motta M (2004) Competition Policy: Theory and Practice (Cambridge University Press, Cambridge, UK).Crossref, Google Scholar
• Shubik M, Levithan R (1980) Market Structure and Behavior (Harvard University Press, Cambridge, MA).Crossref, Google Scholar
• Vishwasrao S (2006) Royalties vs. fees: How do firms pay for foreign technology. Internat. J. Indust. Organ. 25(4):741–759.Crossref, Google Scholar
• Wuyts S, Dutta S (2008) Licensing exchange: Insights from the biopharmaceutical industry. Internat. J. Res. Marketing 25(4):273–281.Crossref, Google Scholar
• Ziedonis AA (2007) Real options in technology licensing. Management Sci. 53(10):1618–1633.Link, Google Scholar